Terms: = Germ cell tumor AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
2984 results:
1. Research progress on function and mechanism of long non-coding RNA in glioma.
Tai F; Zhao X
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):233-237. PubMed ID: 38814211
[TBL] [Abstract] [Full Text] [Related]
2. Optic nerve sheath diameter correlates with both success and failure of hydrocephalus treatment in pediatric patients with pineal region lesions.
Zipfel J; Kerscher SR; Dhillon K; Ferraris KP; Singhal A
Acta Neurochir (Wien); 2024 May; 166(1):236. PubMed ID: 38805061
[TBL] [Abstract] [Full Text] [Related]
3. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma.
Pang JHW; Saffari SE; Lee GR; Yu WY; Lim CCT; Lim KC; Lee CC; Koh WY; Chia WTD; Chua KLM; Tham CK; Low YYS; Ng WH; Low CYD; Lin X
BMC Med Imaging; 2024 May; 24(1):125. PubMed ID: 38802734
[TBL] [Abstract] [Full Text] [Related]
4. [Neurofibromatosis type 1 associated with pheochromocytoma: a case report with a brief review of the literature].
Lugovskaya AY; Britvin TA; Gurevich LE; Rog IS; Nefedova LN; Ilovayskaya IA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):53-64. PubMed ID: 38796761
[TBL] [Abstract] [Full Text] [Related]
5. Racial and Ethnic Disparities in the Incidence of Anti-NMDA Receptor Encephalitis.
Alsalek S; Schwarzmann KB; Budhathoki S; Hernandez-Lopez V; Smith JB; Li BH; Langer-Gould A
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200255. PubMed ID: 38728608
[TBL] [Abstract] [Full Text] [Related]
6. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.
Araujo-Castro M; Biagetti B; Menéndez Torre E; Novoa-Testa I; Cordido F; Pascual-Corrales E; Rodríguez Berrocal V; Guerrero-Pérez F; Vicente A; Percovich Hualpa JC; García-Centeno R; González-Fernández L; Ollero García MD; Irigaray Echarri A; Moure Rodríguez MD; Novo-Rodríguez C; Calatayud M; Villar-Taibo R; Bernabéu I; Alvarez-Escola C; Benítez Valderrama P; Tenorio-Jiménez C; Abellán Galiana P; Venegas E; González-Molero I; Iglesias P; Blanco-Carrera C; Vidal-Ostos De Lara F; de Miguel Novoa P; López Mezquita E; Hanzu FA; Aldecoa I; Aznar S; Lamas C; Aulinas A; Asla Q; Gracia Gimeno P; Recio Córdova JM; Avilés-Pérez MD; Asensio-Wandosell D; Sampedro-Núñez M; Cámara R; Paja Fano M; Ruz-Caracuel I; Fajardo C; Marazuela M; Puig-Domingo M
Endocr Relat Cancer; 2024 Jul; 31(7):. PubMed ID: 38713182
[TBL] [Abstract] [Full Text] [Related]
7. Clinical, Morphological and Molecular Features of Spitz tumors.
Donati M; Mansour B; Hagstrom M; Gerami P; Kazakov DV
Cesk Patol; 2024; 60(1):35-48. PubMed ID: 38697826
[TBL] [Abstract] [Full Text] [Related]
8. Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship Survey.
Jimenez AE; Cicalese KV; Jimenez MA; Chakravarti S; Kuo CC; Lozinsky S; Schwab JH; Knowlton SE; Rowan NR; Mukherjee D
Neurosurg Focus; 2024 May; 56(5):E12. PubMed ID: 38691854
[TBL] [Abstract] [Full Text] [Related]
9. Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant methioninase and a Low-methionine Diet.
Sato M; Han Q; Mizuta K; Mori R; Kang BM; Morinaga S; Kobayashi N; Ichikawa Y; Nakajima A; Hoffman RM
In Vivo; 2024; 38(3):1459-1464. PubMed ID: 38688589
[TBL] [Abstract] [Full Text] [Related]
10. Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.
Tropeano MP; Raspagliesi L; Bono BC; Baram A; Rossini Z; Franzini A; Navarria P; Clerici E; Bellu L; Simonelli M; Scorsetti M; Riva M; Politi LS; Pessina F
Acta Neurochir (Wien); 2024 Apr; 166(1):196. PubMed ID: 38676720
[TBL] [Abstract] [Full Text] [Related]
11. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma.
Hicks RM; Ji X; Zou Y; Sultana S; Rashid R; Sherief ST; Cassoux N; Garcia Leon JL; Diaz Coronado RY; López AMZ; Ushakova TL; Polyakov VG; Roy SR; Ahmad A; Reddy MA; Sagoo MS; Al Harby L; Berry JL; Polski A; Astbury NJ; Bascaran C; Blum S; Bowman R; Burton MJ; Gomel N; Keren-Froim N; Madgar S; Zondervan M; Kaliki S; Fabian ID; Stacey AW
Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):39. PubMed ID: 38662390
[TBL] [Abstract] [Full Text] [Related]
12. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::met fusion.
Chapman N; Greenwald J; Suddock J; Xu D; Markowitz A; Humphrey M; Cotter JA; Krieger MD; Hawes D; Ji J
Acta Neuropathol Commun; 2024 Apr; 12(1):63. PubMed ID: 38650040
[TBL] [Abstract] [Full Text] [Related]
13. A comparison study of dynamic [
Pan Y; Dang H; Zhou H; Fu H; Wu S; Liu H; Zhang J; Wang R; Tian Y; Xu B
J Cancer Res Clin Oncol; 2024 Apr; 150(4):208. PubMed ID: 38647690
[TBL] [Abstract] [Full Text] [Related]
14. FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo.
Mihajlović E; Biancalana L; Jelača S; Chiaverini L; Dojčinović B; Dunđerović D; Zacchini S; Mijatović S; Maksimović-Ivanić D; Marchetti F
J Med Chem; 2024 May; 67(9):7553-7568. PubMed ID: 38639401
[No Abstract] [Full Text] [Related]
15. Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the met pathway in glioblastoma cells.
Chen MS; Chong ZY; Huang C; Huang HC; Su PH; Chen JC
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38606513
[TBL] [Abstract] [Full Text] [Related]
16. Strategies to improve diagnosis and access to treatment of retinoblastoma in low- and middle-income countries: A systematic review.
Rabelo BS; de Alvarenga KAF; Fernando Lopes L; Guimarães Ribeiro A; de Sá Rodrigues KE
Pediatr Blood Cancer; 2024 Jul; 71(7):e30987. PubMed ID: 38594882
[TBL] [Abstract] [Full Text] [Related]
17. Minimally invasive keyhole approach for supramaximal frontal glioma resections: technical note.
Merenzon MA; Mendez Valdez MJ; Chandar J; Lu VM; Marco Del Pont F; Morell AA; Eichberg DG; Daggubati L; Benjamin CG; Shah AH; Ivan ME; Komotar RJ
J Neurosurg; 2024 Apr; 140(4):949-957. PubMed ID: 38564815
[TBL] [Abstract] [Full Text] [Related]
18. Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
Jost J; Völker K; Brandt R; Stummer W; Urbschat S; Ketter R; Wiewrodt D; Wiewrodt R;
J Neurooncol; 2024 May; 168(1):35-45. PubMed ID: 38561565
[TBL] [Abstract] [Full Text] [Related]
19. A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.
Sacco JJ; Jackson R; Corrie P; Danson S; Evans TRJ; Ochsenreither S; Kumar S; Goodman A; Larkin J; Karydis I; Steven N; Lorigan P; Plummer R; Patel P; Psarelli E; Olsson-Brown A; Shaw H; Leyvraz S; Handley L; Rawcliffe C; Nathan P
Eur J Cancer; 2024 May; 202():114009. PubMed ID: 38547774
[TBL] [Abstract] [Full Text] [Related]
20. A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].
Gibson D; Vo AH; Lambing H; Bhattacharya P; Tahir P; Chehab FF; Butowski N
BMC Neurol; 2024 Mar; 24(1):103. PubMed ID: 38521933
[TBL] [Abstract] [Full Text] [Related]
[Next]
